HER-2 overexpression and targeted treatment by trastuzumab in a very old patient with gastric cancer.
Inui
T
T
Inui Clinic, Kagoshima, Japan.
Asakawa
A
A
Morita
Y
Y
Mizuno
S
S
Natori
T
T
Kawaguchi
A
A
Murakami
M
M
Hishikawa
Y
Y
Inui
A
A
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000378:metabolism / Q000556:secondary; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017809:Fatal Outcome; D005784:Gene Amplification / Q000235:genetics; D018734:Genes, erbB-2; D006801:Humans; D007564:Japan; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000556:secondary; D008297:Male; D009363:Neoplasm Proteins / Q000378:metabolism; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D009363:Neoplasm Proteins; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab